Michael M. Mirbaba MD
Addiction
Chief, Department of Addiction Medicine, Kaiser Permanente Los Angeles Medical Center
Join to View Full Profile
1505 N. Edgemont St, 3rd floorLos Angeles, CA 90027
Phone+1 323-783-8206
Dr. Mirbaba is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Addiction Psychiatry, 2016 - 2017- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Psychiatry, 2012 - 2016
Harvard Medical SchoolClass of 2012
Harvard UniversityA.B., Magna cum laude
Certifications & Licensure
CA State Medical License 2013 - 2025
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Addiction Psychiatry
Clinical Trials
- Development of Ibudilast for Alcohol Use Disorder Start of enrollment: 2013 Dec 01
- Naltrexone for Individuals of East Asian Descent Start of enrollment: 2013 Dec 01
- Development of Ivermectin for Alcohol Use Disorders Start of enrollment: 2014 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsPharmacological Options for Smoking Cessation in Heavy-Drinking Smokers.Megan M. Yardley, Michael M. Mirbaba, Lara A. Ray
CNS Drugs. 2015-10-27
Professional Memberships
- Fellow
- American Academy of Addiction PsychiatryMember
- Member
- Member
- California Society of Addiction MedicineMember
- American Society of Clinical PsychopharmacologyMember
Other Languages
- French, Italian, Portuguese, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
